Abstract
Complexin 2 is a cytosolic protein participating in synaptic-vesicle exocytosis. The RT-PCR technique was used in a real-time study of the dynamics of variation of expression of the Cplx2 gene that encodes this protein. The study was performed in the rat brain. Measurements under the conditions of incomplete global ischemia were performed during 1 day; measurements under the conditions of focal ischemia were carried out 3, 24, and 72 h after irreversible occlusion of the medial cerebral artery. The most significant decrease in Cplx2 transcripts under the conditions of incomplete global ischemia was observed in the hippocampus and the frontal cortex of rats 12 and 24 h after irreversible occlusion of the common carotid arteries, respectively. Under conditions of focal ischemia, a decrease in the content of Cplx2 transcripts was observed only in focal lesions of the frontoparietal cortex 24 h after occlusion. The effect of Semax neuroprotector peptide and its C-terminal fragment Pro-Gly-Pro on Cplx2 expression was examined under the model ischemia conditions. In the case of incomplete global ischemia, application of Semax compensated for the maximum decrease in Cplx2 expression in the frontal cortex and hippocampus in rats caused by lesions. However, the peptide had no effect when used in rats with focal ischemia. The effect of PGP on Cplx2 expression under conditions of experimental ischemia was more complicated and did not always coincide with the effect of Semax. The obtained results provide insight into the specific features of Cplx2 expression under the conditions of experimental brain ischemia and help to better understand the mechanisms of activity of peptide preparations.
Similar content being viewed by others
References
Hofmeijer, J. and van Putten, M.J., Ischemic cerebral damage: An appraisal of synaptic failure, Stroke, 2012, vol. 43, no. 2, pp. 607–615.
Pabst, S., Hazzard, J.W., Antonin, W., Südhof, T.C., Jahn, R., Rizo, J., et al., Selective interaction of complexin with the neuronal SNARE complex. Determination of the binding regions, J. Biol. Chem., 2000, vol. 275, no. 26, pp. 19808–19818.
Neher, E., Complexin: does it deserve its name?, Neuron, 2010, vol. 68, no. 5, pp. 803–806.
Hazell, A.S. and Wang, D., Identification of complexin IIin astrocytes: A possible regulator of glutamate release in these cells, Biochem. Biophys. Res. Commun., 2011, vol. 404, no. 1, pp. 228–232.
Wang, Z., Wei, X., Liu, K., Zhang, X., Yang, F., Zhang, H., et al., NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke, Free Radical Biol. Med., 2013, vol. 65, pp. 942–951.
Yakovleva, E.V., Kuzenkov, V.S., Fedorov, V.N., Skvortsova, V.I., Koshelev, V.B., Gusev, E.I., et al., In vivo efficiency of Semax in global cerebral ischemia, Bull. Exp. Biol. Med., 1999, vol. 128, no. 2, pp.806–807.
Gusev, E.I., Skvortsova, V.I., Myasoedov, N.F., Nezavibat’ko, V.N., Zhuravleva, E.I., and Vanichkin, A.V., Semax efficiency in acute period of hemispheric ischemic stroke, Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 1997, vol. 97, pp. 26–34.
Myasoedov, N.F., Skvortsova, V.I., Nasonov, E.L., Zhuravleva, E.I., Grivennikov, I.A., Arsen’eva, E.L., et al., Semax neuroprotective effect in acute period of ischemic stroke, Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 1999, vol. 99, pp. 15–19.
Alekseeva, G.V., Bottaeva, N.A., and Gorshkova, V.V., Semax usage in patients with post-hypoxic brain pathology for long-term period, Anesteziol. Reanimatol., 1999, vol. 1, pp. 40–43.
Kaplan, A.I., Koshelev, V.B., Nezavibat’ko, V.N., and Ashmarin, I.P., The way to increase an organism resistance against hypoxia with the help of neuropeptide drug Semax, Fiziol. Chel., 1992, vol. 18, no. 5, pp. 104–107.
Storozhevykh, T.P., Tukhbatova, G.R., Senilova, Ya.E., Pinelis, V.G., Andreeva, L.A., and Myasoedov, N.F., Effects of Semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity, Bull. Exp. Biol. Med., 2007, vol. 143, no. 5, pp. 601–604.
Martynova, K.V., Andreeva, L.A., Klimova, P.A., Kirillova, Yu.G., Shevchenko, V.P., Nagaev, I.Yu., et al., Structural-functional study of glycine-and-proline- containing peptides (glyprolines) as potential neuroprotectors, Russ. J. Bioorg. Chem., 2009, vol. 35, no. 2, pp. 150–156.
Dmitrieva, V.G., Dergunova, L.V., Povarova, O.V., Skvortsova, V.I., Limborskaya, S.A., and Myasoedov, N.F., The effect of Semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia, Dokl. Biochem. Biophys., 2008, vol. 422, pp. 261–264.
Dmitrieva, V.G., Povarova, O.V., Skvortsova, V.I., Limborska, S.A., Myasoedov, N.F., and Dergunova, L.V., Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia, Cell. Mol. Neurobiol., 2010, vol. 30, no. 1, pp. 71–79.
Stavchansky, V.V., Tvorogova, T.V., Botsina, A.Yu., Skvortsova, V.I., Limborska, S.A., Myasoedov, N.F., and Dergunova, L.V., Effect of Semax and its C-terminal peptide PGP on expression of neurotrophins and their receptors in rat brain during incomplete global ischemia, Mol. Biol. (Moscow), 2011, vol. 45, no. 6, pp. 941–949.
Raevskaya, N.M., Dergunova, L.V., Vladychenskaya, I.P., Stavchansky, V.V., Oborina, M.V., Poltaraus, A.B., et al., Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity, Gene, 2005, vol. 359, pp. 127–137.
Dmitrieva, V.G., Torshina, E.V., Yuzhakov, V.V., Povarovac, O.V., Skvortsova, V.I., Limborska, S.A., et al., Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia, Brain Res., 2008, vol. 1188, pp. 222–227.
Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res., 2001, vol. 29, no. 9, pp. 2002–2007.
Pfaffl, M.W., Horgan, G.W., and Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res., 2002, vol. 30, no. 9, p. e36.
Sieber, F.E., Palmon, S.C., Traystman, R.J., and Martin, L.J., Global incomplete cerebral ischemia produces predominantly cortical neuronal injury, Stroke, 1995, vol. 26, pp. 2091–2096.
Stavchansky, V.V., Yuzhakov, V.V., Botsina, A.Y., Skvortsova, V.I., Bondurko, L.N., Tsyganova, M.G., et al., The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study, J. Mol. Neurosci., 2011, vol. 45, no. 2, pp. 177–185.
Astashkin, E.I., Bespalova, Yu.B., Grivennikov, I.A., Smirnov, O.N., Glezer, M.G., Grachev, S.V., and Myasoedov, N.F., Effects of Semax on Ca2+ responses of human neutrophils, Dokl. Biol. Sci., 2000, vol. 374, pp. 536–538.
Bashkatova, V.G., Koshelev, V.B., Fadyukova, O.E., Alexeev, A.A., Vanin, A.F., Rayevsky, K.S., Ashmarin, I.P., and Armstrong, D.M., Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia, Brain Res., 2001, vol. 894, pp. 145–149.
Medvedeva, E.V., Dmitrieva, V.G., Povarova, O.V., Limborska, S.A., Skvortsova, V.I., Myasoedov, N.F., et al., The peptide Semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis, BMC Genomics, 2014, vol. 15, p. 228. http://www.biomedcentral.com/1471-2164/15/228.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.V. Stavchansky, E.O. Kurichenkova, V.G. Dmitrieva, N.F. Myasoedov, S.A. Limborska, L.V. Dergunova, 2016, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2016, No. 4, pp. 137–142.
About this article
Cite this article
Stavchansky, V.V., Kurichenkova, E.O., Dmitrieva, V.G. et al. Cplx2 gene expression following semax or PGP administration under conditions of two experimental models of rat-brain ischemia. Mol. Genet. Microbiol. Virol. 31, 214–219 (2016). https://doi.org/10.3103/S0891416816040078
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416816040078